Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24100TG2011PTC148362 Incorporated 29 August 2011 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹67.68 Lakh
▼ 12.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹5.01 Cr
Issued & subscribed
Open charges
None
Satisfied ₹20 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
3
Latest available

About Be Pharmaceuticals Private Limited

Data last updated: 20 December 2025

Be Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Biological E Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 29 August 2011, the company has been in operation for over 15 years.

Registered with ROC Hyderabad under CIN U24100TG2011PTC148362.

Capital: an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.01 Cr. Formerly known as Akorn India Private Limited. It is led by directors including Rudaraju Anand Kumar and Mahipal Reddy Saddi.

Last AGM: 18 September 2024. Financial statements filed for year ended 31 March 2024. Office: 18/1 & 3 Azamabad, Hyderabad, Telangana, India – 500020.

As per the financials filed for FY 2025, the company reported a revenue of ₹67.68 Lakh, a decline of 12% compared to the previous year.

The company has a workforce of approximately 3 employees as per the latest available data. It operates as a subsidiary of Biological E Limited.

The company is associated with 1 brand - Akorn India. As per MCA filings, the company has satisfied charges of ₹20 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website akornindia.com.

Company Details of Be Pharmaceuticals Private Limited
CIN U24100TG2011PTC148362
Registration Number 148362
Incorporation Date 29 August 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Biological E Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    18/1 & 3 Azamabad, Hyderabad, Telangana, India – 500020
  • Industry
    Pharma, Drug Formulation & Development
Company report
Be Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Be Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Be Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG2011PTC148362, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24100TG2011PTC148362 Current
U24100MH2011PTC221406 Previous
U24100DL2011PTC262196 Previous

Associated Brands with Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited operates one associated brand: Akorn India. These brands represent Be Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Sterile pharmaceuticals are developed, manufactured, and marketed by Akorn India. akornindia.com

Competitors & Alternatives of Be Pharmaceuticals Private Limited

Brands and companies operating in the same space as Be Pharmaceuticals Private Limited include Exela Pharma, Gland Pharma, Luoxin Pharmaceutical Group and 6 more.

Competitor Description Location Founded
Exela Pharma Exela Pharma Sterile injectable pharmaceuticals are manufactured alongside CDMO services. Lenoir, United States, United States 2005
Gland Pharma Gland Pharma Generic injectable drugs are manufactured across therapeutic segments. Hyderabad, India, India 1978
Luoxin Pharmaceutical Group Luoxin Pharmaceutical Group Developer and manufacturer of pharmaceutical products Linyi, China, China 2006
Summit Biosciences Summit Biosciences Nasal spray drug products are developed, manufactured, and commercialized. Lexington, United States, United States 2008
August Bioservices August Bioservices Diversified research services for clinical solutions are offered. Nashville, United States, United States 2017
ApiJect ApiJect Medicine injectors are manufactured by ApiJect for medical applications. Stamford, United States, United States 2015
Vetter Pharma Vetter Pharma CDMO specializing in aseptically prefilled syringe systems, cartridges and vials. Ravensburg, Germany, Germany 1950
INCOG BioPharma Services INCOG BioPharma Services Injectable drug products are manufactured by this biopharma CDMO. United States 2020
Nitin Lifesciences Nitin Lifesciences CMO of small volume parenteral injectables Karnal, India, India 1994

Business Activity of Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Be Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited is audited by DAT LA & ASSOCIATES for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
DAT LA & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Be Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited is currently managed by 3 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rudaraju Anand Kumar Director 14 Aug 2020 5 Years 11 Months Current
Mahipal Reddy Saddi Director 26 Aug 2020 5 Years 11 Months Current
Mahima Datla Director 14 Aug 2020 5 Years 11 Months Current

Financials of Be Pharmaceuticals Private Limited FY 2024 filings available

Be Pharmaceuticals Private Limited reported revenue of ₹67.68 Lakh (down 12.00% YoY) for FY 2025.

Revenue · FY 2025
₹67.68 Lakh ▼ 12.00%
Premium access

Ten-year financial statements for Be Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Be Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Be Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Be Pharmaceuticals Private Limited

Open charges
₹0
Satisfied charges
₹20 Cr
Breakdown by lending institutions
Icici Bank Limited₹20.00 Cr
Latest charge details
DateLenderAmountStatus
25 Jul 2014 Icici Bank Limited ₹20 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited has a workforce of 3 employees as of Mar 31, 2025.

Employee count
3
Active EPFO establishments
3
Employee growth
-98.65%
Premium access

Employee and EPFO history for Be Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Be Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Be Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Be Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Be Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Be Pharmaceuticals Private Limited

Premium access

MSME payment history for Be Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Be Pharmaceuticals Private Limited

Premium access

Corporate group structure for Be Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Be Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Be Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Be Pharmaceuticals Private Limited

Activity
18 Sep 2024
Be Pharmaceuticals Private Limited last Annual general meeting of members was held on 18 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Be Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Directors
26 Aug 2020
Mahipal Reddy Saddi was appointed as a Director on 26 Aug 2020 & has been associated with this company since 5 years 11 months.
Directors
14 Aug 2020
Rudaraju Anand Kumar was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 11 months.
Directors
14 Aug 2020
Mahima Datla was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 11 months.
Charges
29 Jan 2015
A charge registered on 25 Jul 2014 via Charge ID 10522225 with Icici Bank Limited was fully satisfied on 29 Jan 2015.

Frequently Asked Questions about Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 29 August 2011 (15+ years old) and is registered under CIN U24100TG2011PTC148362. The company has 3 employees.

Be Pharmaceuticals Private Limited reported revenue of ₹67.68 Lakh for FY 2025 (down 12.00% YoY).

The current directors of Be Pharmaceuticals Private Limited are:

The primary industry of Be Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Be Pharmaceuticals Private Limited can be reached at the registered office: 181 & 3 Azamabad, Hyderabad, Telangana, India – 500020, or through the website akornindia.com.

The authorised capital is ₹6 Cr, and the paid-up capital is ₹5.01 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available